Page last updated: 2024-11-08

biguanides and Animal Mammary Carcinoma

biguanides has been researched along with Animal Mammary Carcinoma in 1 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Research Excerpts

ExcerptRelevanceReference
"We show here that breast tumors engage the ShcA pathway to increase their metabolism."1.48Interplay between ShcA Signaling and PGC-1α Triggers Targetable Metabolic Vulnerabilities in Breast Cancer. ( Ahn, R; Avizonis, DZ; Chénard, V; Gravel, SP; Hudson, J; Im, YK; McGuirk, S; Najyb, O; Pawson, T; Pollak, M; Sabourin, V; St-Pierre, J; Topisirovic, I; Ursini-Siegel, J, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Im, YK1
Najyb, O1
Gravel, SP1
McGuirk, S1
Ahn, R1
Avizonis, DZ1
Chénard, V1
Sabourin, V1
Hudson, J1
Pawson, T1
Topisirovic, I1
Pollak, M1
St-Pierre, J1
Ursini-Siegel, J1

Other Studies

1 other study available for biguanides and Animal Mammary Carcinoma

ArticleYear
Interplay between ShcA Signaling and PGC-1α Triggers Targetable Metabolic Vulnerabilities in Breast Cancer.
    Cancer research, 2018, 09-01, Volume: 78, Issue:17

    Topics: Animals; Biguanides; Breast Neoplasms; Disease Models, Animal; Female; Humans; Mammary Neoplasms, An

2018